|
Vaccine Detail
ALVAC-RHDV (vCP309) |
Vaccine Information |
- Vaccine Name: ALVAC-RHDV (vCP309)
- Target Pathogen: Rabbit hemorrhagic disease virus
- Target Disease: Rabbit hemorrhagic disease
- Vaccine Ontology ID: VO_0004738
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- Vector:
- Preparation: An ALVAC (canarypox)-based recombinant virus ALVAC-RHDV (vCP309) expressing a native rabbit hemorrhagic disease virus (RHDV) capsid protein was derived and assessed for its protective efficacy in rabbits (Fischer et al., 1997).
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Rabbit Response
- Vaccination Protocol: Rabbits were inoculated with varying doses of vCP309 (Fischer et al., 1997).
- Vaccine Immune Response Type: VO_0003057
- Challenge Protocol: Rabbits were challenged with RHDV (Fischer et al., 1997).
- Efficacy: Protection against a lethal RHDV challenge was demonstrated in rabbits inoculated twice with either high (10(7) p.f.u.) or low (10(5) p.f.u.) doses of vCP309. However, animals in the high dose group developed significantly higher antibody response (Fischer et al., 1997).
|
References |
Fischer et al., 1997: Fischer L, Le Gros FX, Mason PW, Paoletti E. A recombinant canarypox virus protects rabbits against a lethal rabbit hemorrhagic disease virus (RHDV) challenge. Vaccine. 1997; 15(1); 90-96. [PubMed: 9041672].
|
|